RNA-binding protein with serine-rich domain 1 regulates the survival and progression of pancreatic cancer cells through the Notch signaling pathway

Song Haiyan; Zhu Zhendong; Yu Xiaomin; Zhang Yimin

doi:10.13406/j.cnki.cyxb.003602

您当前的位置：

首页 >

文章列表页 >

RNA-binding protein with serine-rich domain 1 regulates the survival and progression of pancreatic cancer cells through the Notch signaling pathway

Basic research | 更新时间：2025-10-23

- RNA-binding protein with serine-rich domain 1 regulates the survival and progression of pancreatic cancer cells through the Notch signaling pathway
- Journal of Chongqing Medical University Vol. 49, Issue 10, Pages: 1088-1094(2024)
- 作者机构：
  
  新乡医学院基础医学院，新乡 453003
- 作者简介：
- 基金信息：
- DOI：10.13406/j.cnki.cyxb.003602
  CLC： R361⁺.3
- Received：20 October 2023，
  
  Revised：2024-02-26，
  
  Accepted：19 March 2024，
  
  Published：28 October 2024
- 稿件说明：
移动端阅览
宋海岩,朱振东,余筱敏,等.RNPS1通过Notch信号通路参与调控胰腺癌细胞的生存及进展[J].重庆医科大学学报,2024,49(10):1088-1094.

Song Haiyan,Zhu Zhendong,Yu Xiaomin,et al.RNA-binding protein with serine-rich domain 1 regulates the survival and progression of pancreatic cancer cells through the Notch signaling pathway[J].Journal of Chongqing Medical University,2024,49(10):1088-1094.
宋海岩,朱振东,余筱敏,等.RNPS1通过Notch信号通路参与调控胰腺癌细胞的生存及进展[J].重庆医科大学学报,2024,49(10):1088-1094. DOI： 10.13406/j.cnki.cyxb.003602.

Song Haiyan,Zhu Zhendong,Yu Xiaomin,et al.RNA-binding protein with serine-rich domain 1 regulates the survival and progression of pancreatic cancer cells through the Notch signaling pathway[J].Journal of Chongqing Medical University,2024,49(10):1088-1094. DOI： 10.13406/j.cnki.cyxb.003602.

摘要

目的

探讨富含丝氨酸结构域1的RNA结合蛋白（RNA-binding protein with serine-rich domain 1，RNPS1）在胰腺癌进展中的作用及可能分子机制。

方法

免疫组织化学与免疫荧光检测RNPS1与Notch3在胰腺癌组织及癌旁组织的表达；RT-qPCR、免疫荧光检测RNPS1与Notch3在胰腺癌细胞中的表达情况；Hoechst与CCK-8实验检测胰腺癌细胞凋亡与增殖；划痕实验与transwell实验检测胰腺癌细胞迁移与侵袭能力；Western blot实验检测胰腺癌细胞中N-Cadherin和E-Cadherin的表达；Western blot与RT-qPCR实验检测胰腺癌细胞中Notch3与HEY1的表达。

结果

与癌旁组织与正常细胞系相比较，RNPS1与Notch3在胰腺癌组织中及胰腺癌细胞的表达均增高（

=121.612、34.649，均

0.05）；与对照组相比较，敲低RNPS1抑制生物标志物N-Cadherin的表达（

=39.922，

0.05），促进E-Cadherin的表达（

=8.281，

0.05），敲低RNPS1可减弱癌细胞的生存、迁移侵袭的能力（

=2.017、4.874、19.747，均

0.05，），促进了细胞凋亡（

=33.673，

0.05）；敲低RNPS1降低了癌细胞中Notch3与HEY1的表达（

=17.546、6.258，均

0.05）。

结论

RNPS1的表达与胰腺癌细胞生存、恶性表型有关，RNPS1可能通过调控Notch3/HEY1信号通路促进胰腺癌细胞的生存及肿瘤进展。

Abstract

Objective

To investigate the role and possible molecular mechanism of RNA-binding protein with serine-rich domain 1 （RNPS1） in the progression of pancreatic cancer.

Methods

Immunohistochemistry and immunofluorescence assay were used to measure the expression of RNPS1 and Notch3 in pancreatic cancer tissue and paracancerous tissue，and RT-qPCR and immunofluorescence assay were used to measure the expression of RNPS1 and Notch3 in pancreatic cancer cells. Hoechst staining and CCK-8 assay were used to measure the apoptosis and proliferation of pancreatic cancer cells； Wound healing assay and Transwell assay were used to observe the migration and invasion abilities of pancreatic cancer cells； Western blot was used to measure the expression of N-Cadherin and E-Cadherin in pancreatic cancer cells，and Western blot and RT-qPCR were used to measure the expression of Notch3 and HEY1 in pancreatic cancer cells.

Results

There were significant increases in the expression levels of RNPS1 and Notch3 in pancreatic cancer tissue and pancreatic cancer cells compared with the paracancerous tissue and normal cell lines（

=121.612 and 34.649，all

0.05）. Comparing with the control group，RNPS1 knockdown inhibited the expression of the biomarker N-Cadherin（

=39.922，

0.05），promoted the expression of E-Cadherin（

=8.281，

0.05），reduced the survival，migration，and invasion abilities of cancer cells（

=2.017，4.874，and 19.747，all

0.05），and promoted cancer cell apoptosis（

=33.673，

0.05）. In addition，RNPS1 knockdown reduced the expression levels of Notch3 and HEY1 in cancer cells（

=17.546 and 6.258，all

0.05）.

Conclusion

The expression of RNPS1 is associated with the survival and malignant phenotype of pancreatic cancer cells，and RNPS1 may promote the survival of pancreatic cancer cells and the progression of pancreatic cancer by regulating the Notch3/HEY1 signaling pathway.

关键词

Keywords

references

Siegel RL ， Miller KD ， Jemal A . Cancer statistics，2016 [J ] . CA Cancer J Clin ， 2016 ， 66 （ 1 ）： 7 - 30 ．

Kahles A ， Lehmann KV ， Toussaint NC ， et al . Comprehensive analysis of alternative splicing across tumors from 8，705 patients [J ] . Cancer Cell ， 2018 ， 34 （ 2 ）： 211 - 224 .

Sciarrillo R ， Wojtuszkiewicz A ， Assaraf YG ， et al . The role of alternative splicing in cancer：from oncogenesis to drug resistance [J ] . Drug Resist Updat ， 2020 ， 53 ： 100728 ．

Bradley RK ， Anczuków O . RNA splicing dysregulation and the hallmarks of cancer [J ] . Nat Rev Cancer ， 2023 ， 23 （ 3 ）： 135 - 155 ．

Bonnal SC ， López-Oreja I ， Valcárcel J . Roles and mechanisms of alternative splicing in cancer—implications for care [J ] . Nat Rev Clin Oncol ， 2020 ， 17 ： 457 - 474 ．

Wang XL ， Li JX ， Bian X ， et al . CircURI1 interacts with hnRNPM to inhibit metastasis by modulating alternative splic ing in gastric cancer [J ] . Proc Natl Acad Sci U S A ， 2021 ， 118 （ 33 ）： e2012881118 ．

Peng Q ， Zhou YJ ， Oyang L ， et al . Impacts and mechanisms of alternative mRNA splicing in cancer metabolism，immune response，and therapeutics [J ] . Mol Ther ， 2022 ， 30 （ 3 ）： 1018 - 1035 ．

Mehterov N ， Kazakova M ， Sbirkov Y ， et al . Alternative RNA splicing-the Trojan horse of cancer cells in chemotherapy [J ] . Genes ， 2021 ， 12 （ 7 ）： 1085 ．

Deka B ， Chandra P ， Yadav P ， et al . RNPS1 functions as an oncogenic splicing factor in cervical cancer cells [J ] . IUBMB Life ， 2023 ， 75 （ 6 ）： 514 - 529 ．

Liu XJ ， Ma H ， Ma LS ， et al . RNA-binding protein with serine-rich domain 1 regulates microsatellite instability of uterine corpus endometrial adenocarcinoma [J ] . Clinics ， 2021 ， 76 ： e3318 ．

Strobel O ， Neoptolemos J ， Jäger D ， et al . Optimizing the outcomes of pancreatic cancer surgery [J ] . Nat Rev Clin Oncol ， 2019 ， 16 （ 1 ）： 11 - 26 .

Sano M ， Takahashi R ， Ijichi H ， et al . Blocking VCAM-1 inhibits pancreatic tumour progression and cancer-associated thrombosis/thromboembolism [J ] . Gut ， 2021 ， 70 （ 9 ）： 1713 - 1723 ．

Liang C ， Shi S ， Qin Y ， et al . Localisation of PGK1 determines metabolic phenotype to balance metastasis and proliferation in patients with SMAD4-negative pancreatic cancer [J ] . Gut ， 2020 ， 69 （ 5 ）： 888 - 900 .

Bashari A ， Siegfried Z ， Karni R . Targeting splicing factors for cancer therapy [J ] . RNA ， 2023 ， 29 （ 4 ）： 506 - 515 ．

Prashad S ， Gopal PP . RNA-binding proteins in neurological development and disease [J ] . RNA Biol ， 2021 ， 18 （ 7 ）： 972 - 987 ．

Deng SF ， Yi P ， Xu ML ， et al . Dysfunctional gene splicing in glucose metabolism may contribute to Alzheimer's disease [J ] . Chin Med J ， 2023 ， 136 （ 6 ）： 666 - 675 ．

Sertznig H ， Roesmann F ， Wilhelm A ， et al . SRSF1 acts as an IFN-I-regulated cellular dependency factor decisively affecting HIV-1 post-integration steps [J ] . Front Immunol ， 2022 ， 13 ： 935800 ．

Yoshimi A ， Lin KT ， Wiseman DH ， et al . Coordinated alterations in RNA splicing and epigenetic regulation drive leukaemogenesis [J ] . Nature ， 2019 ， 574 （ 7777 ）： 273 - 277 ．

Tripathi V ， Shin JH ， Stuelten CH ， et al . TGF-β-induced alternative splicing of TAK1 promotes EMT and drug resistance [J ] . Oncogene ， 2019 ， 38 （ 17 ）： 3185 - 3200 ．

Zhang HH ， Brown RL ， Wei Y ， et al . CD44 splice isoform switching determines breast cancer stem cell state [J ] . Genes Dev ， 2019 ， 33 （ 3/4 ）： 166 - 179 ．

Li J ， Choi PS ， Chaffer CL ， et al . An alternative splicing switch in FLNB promotes the mesenchymal cell state in human breast cancer [J ] . Elife ， 2018 ， 7 ： e37184 ．

McCracken S ， Longman ， Johnstone IL ， et al . An evolutionarily conserved role for SRm160 in 3'-end processing that functions independently of exon junction complex formation [J ] . J Biol Chem ， 2003 ， 278 （ 45 ）： 44153 - 44160 ．

Fukumura K ， Inoue K ， Mayeda A . Splicing activator RNPS1 suppresses errors in pre-mRNA splicing：a key factor for mRNA quality control [J ] . Biochem Biophys Res Commun ， 2018 ， 496 （ 3 ）： 921 - 926 ．

Zhang Z ， Guo MD ， Liu Y ， et al . RNPS1 inhibition aggravates ischemic brain injury and promotes neuronal death [J ] . Biochem Biophys Res Commun ， 2020 ， 523 （ 1 ）： 39 - 45 ．

Wang CX ， Zheng MJ ， Wang S ， et al . Whole genome analysis and prognostic model construction based on alternative splicing events in endometrial cancer [J ] . Biomed Res Int ， 2019 ， 2019 ： 2686875 ．

Liu Y ， Jia WX ， Li J ， et al . Identification of survival-associated alternative splicing signatures in lung squamous cell carcinoma [J ] . Front Oncol ， 2020 ， 10 ： 587343 ．

Syed V ， Zhang X ， Lau KM ， et al . Profiling estrogen-regulated gene expression changes in normal and malignant human ovarian surface epithelial cells [J ] . Oncogene ， 2005 ， 24 （ 55 ）： 8128 - 8143 ．

Pedrosa AR ， Trindade A ， Carvalho C ， et al . Endothelial Jagged1 promotes solid tumor growth through both pro-angiogenic and angiocrine functions [J ] . Oncotarget ， 2015 ， 6 （ 27 ）： 24404 - 24423 ．

Chiu TJ ， Chen YJ ， Lan J ， et al . Downregulation of Notch3 links TIMP3 inhibition to suppress aggressive phenotypes of pancreatic ductal adenocarcinoma [J ] . Am J Cancer Res ， 2021 ， 11 （ 11 ）： 5609 - 5624 ．

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Mechanism of anthrax toxin receptor 2 expression regulated by miR-145-5p in pancreatic cancer

Effect of phospholipase PLCD1 on epithelial-mesenchymal transition of pancreatic cancer cells CAPAN-1 and BXPC-3

Different doses of gemcitabine chemotherapy after radical resection of pancreatic cancer:a randomized controlled clinical study

Inhibition of human pancreatic cancer cell after Adenovirus-mediated connective tissue growth factor(CTGF) over-expression

Value of 18F-fluorodeoxyglucose PET/CT combined with pancreatic tumor markers in the diagnosis of recurrence and metastasis after surgery for early resectable pancreatic cancer

Related Author

Li Jianshui

Huang Xiaobin

Tang Haoyou

Liu Sheng

Lan Chuan

Deng Dawei

Ma Lin

Jiang Zheng

Related Institution

Second Department of Hepatobiliary Surgery，Institute of Hepatobiliary，Pancreatic and Intestine， North Sichuan Medical College

Department of Gastroenterology，The First Affiliated Hospital of Chongqing Medical University

Department of Surgery,Shaoyang Central Hospital of Hunan Province

Department of Hepatobiliary Surgery,the Children’s Hospital,Chongqing Medical University

Department of Oncology，The Affiliated Hospital of Southwest Medical University

⁰